https://www.avient.com/sites/default/files/2022-11/Avient Announces Third Quarter 2022 Results.pdf
https://www.avient.com/investors
https://edge.media-server.com/mmc/p/fqwbh5zv
https://www.avient.com/investors
https://register.vevent.com/register/BI3f68f18c2b10416fa722221e3f01ea50
https://www.avient.com/investors/events-presentations
4
About Avient
Avient Corporation (NYSE: AVNT) provides specialized and sustainable material solutions that
transform customer challenges into opportunities, bringing new products to life for a better world.
2) Tax adjustments include the net tax benefit/ (expense) from one-time income tax items, the set-up or reversal of uncertain tax position reserves
and deferred income tax valuation allowance adjustments.
10
Attachment 4
Avient Corporation
Condensed Consolidated Balance Sheets
(In millions)
(Unaudited)
September 30, 2022
December 31,
2021
ASSETS
Current assets:
Cash and cash equivalents $ 544.4 $ 601.2
Accounts receivable, net 504.6 439.9
Inventories, net 441.5 305.8
Current assets held for sale 367.8 360.2
Other current assets 130.0 119.9
Total current assets 1,988.3 1,827.0
Property, net 965.4 672.3
Goodwill 1,491.0 1,284.8
Intangible assets, net 1,525.7 925.2
Operating lease assets, net 56.0 58.2
Non-current assets held for sale — 22.0
Other non-current assets 280.7 207.7
Total assets $ 6,307.1 $ 4,997.2
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Short-term and current portion of long-term debt $ 613.9 $ 8.6
Accounts payable 448.7 429.5
Current operating lease obligations 18.1 21.1
Current liabilities held for sale 170.3 141.3
Accrued expenses and other current liabilities 304.6 340.2
Total current liabilities 1,555.6 940.7
Non-current liabilities:
Long-term debt 2,502.9 1,850.3
Pension and other post-retirement benefits 91.6 99.9
Deferred income taxes 210.4 100.6
Non-current operating lease obligations 35.7 37.3
Non-current liabilities held for sale — 13.1
Other non-current liabilities 174.8 164.8
Total non-current liabilities 3,015.4 2,266.0
SHAREHOLDERS' EQUITY
Avient shareholders’ equity 1,720.4 1,774.7
Noncontrolling interest 15.7 15.8
Total equity 1,736.1 1,790.5
Total liabilities and equity $ 6,307.1 $ 4,997.2
11
Attachment 5
Avient Corporation
Condensed Consolidated Statements of Cash Flows (Unaudited)
(In millions)
Nine Months Ended
September 30,
2022 2021
Operating Activities
Net income $ 158.5 $ 201.7
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 110.3 105.8
Accelerated depreciation 4.0 1.9
Share-based compensation expense 9.5 8.4
Changes in assets and liabilities, net of the effect of acquisitions:
Increase in accounts receivable (66.5) (199.7)
Increase in inventories (12.5) (156.2)
Increase in accounts payable 43.5 95.3
Decrease in pension and other post-retirement benefits (15.8) (14.2)
(Decrease) increase in accrued expenses and other assets and liabilities, net (7.1) 67.0
Net cash provided by operating activities 223.9 110.0
Investing activities
Capital expenditures (55.1) (62.7)
Business acquisitions, net of cash acquired (1,426.1) (47.6)
Settlement of foreign exchange derivatives 93.3 —
Net cash proceeds used by other assets — (2.0)
Net cash used by investing activities (1,387.9) (112.3)
Financing activities
Debt proceeds 1,300.0 —
Purchase of common shares for treasury (36.4) (4.2)
Cash dividends paid (65.2) (58.2)
Repayment of long-term debt (6.8) (16.5)
Payments of withholding tax on share awards (4.2) (9.1)
Debt financing costs (49.3) —
Other financing activities — (3.5)
Net cash provided (used) by financing activities 1,138.1 (91.5)
Effect of exchange rate changes on cash (30.9) (10.5)
Decrease in cash and cash equivalents (56.8) (104.3)
Cash and cash equivalents at beginning of year 601.2 649.5
Cash and cash equivalents at end of period $ 544.4 $ 545.2
12
Attachment 6
Avient Corporation
Business Segment Operations (Unaudited)
(In millions)
Operating income and earnings before interest, taxes, depreciation and amortization (EBITDA) at the segment level does not
include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to segments;
intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not included in the
measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker.
https://www.avient.com/sites/default/files/2023-02/AVNT Q4 2022 Earnings Press Release-1.pdf
https://www.avient.com/news
4
Pro Forma for Acquisition of Avient Protective Materials business (APM)
On September 1, 2022, the company acquired DSM’s Protective Materials business, the foundation
of which is the renowned technology and globally admired brand of Dyneema®, the World’s
Strongest Fiber™.
2) Tax adjustments include the net tax benefit/(expense) from non-recurring income tax items, adjustments to uncertain tax position reserves and
deferred income tax valuation allowances.
11
Attachment 4
Avient Corporation
Condensed Consolidated Balance Sheets (Unaudited)
(In millions)
Year Ended
December 31,
2022 2021
ASSETS
Current assets:
Cash and cash equivalents $ 641.1 $ 601.2
Accounts receivable, net 440.6 439.9
Inventories, net 372.7 305.8
Current assets held for sale — 360.2
Other current assets 115.3 119.9
Total current assets 1,569.7 1,827.0
Property, net 1,049.2 672.3
Goodwill 1,671.9 1,284.8
Intangible assets, net 1,597.6 925.2
Operating lease assets, net 60.4 58.2
Non-current assets held for sale — 22.0
Other non-current assets 136.2 207.7
Total assets $ 6,085.0 $ 4,997.2
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Short-term and current portion of long-term debt $ 2.2 $ 8.6
Accounts payable 454.4 429.5
Current operating lease obligations 17.0 21.1
Current liabilities held for sale — 141.3
Accrued expenses and other current liabilities 395.8 340.2
Total current liabilities 869.4 940.7
Non-current liabilities:
Long-term debt 2,176.7 1,850.3
Pension and other post-retirement benefits 67.2 99.9
Deferred income taxes 342.5 100.6
Non-current operating lease obligations 40.9 37.3
Non-current liabilities held for sale — 13.1
Other non-current liabilities 235.5 164.8
Total non-current liabilities 2,862.8 2,266.0
SHAREHOLDERS' EQUITY
Avient shareholders’ equity 2,334.5 1,774.7
Noncontrolling interest 18.3 15.8
Total equity 2,352.8 1,790.5
Total liabilities and equity $ 6,085.0 $ 4,997.2
12
Attachment 5
Avient Corporation
Condensed Consolidated Statements of Cash Flows (Unaudited)
(In millions)
Year Ended
December 31,
2022 2021
Operating activities
Net income $ 703.4 $ 230.6
Adjustments to reconcile net income to net cash provided by operating activities:
Gain on sale of business, net of tax expense (550.1) —
Depreciation and amortization 157.6 144.2
Accelerated depreciation 5.5 1.7
Amortization of inventory step-up 34.4 1.5
Deferred income tax expense (benefit) 0.5 (27.3)
Share-based compensation expense 13.2 11.2
Changes in assets and liabilities, net of the effect of acquisitions:
Decrease (increase) in accounts receivable 32.6 (143.1)
Decrease (increase) in inventories 14.0 (141.0)
Increase in accounts payable 10.7 95.3
Increase (decrease) in pension and other post-retirement benefits 7.1 (10.9)
Taxes paid on gain on divestiture (2.8) —
(Decrease) increase in accrued expenses and other assets and liabilities, net (27.7) 71.6
Net cash provided by operating activities 398.4 233.8
Investing activities
Capital expenditures (105.5) (100.6)
Business acquisitions, net of cash acquired (1,426.1) (47.6)
Settlement of foreign exchange derivatives 93.3 —
Proceeds from divestiture 928.2 —
Other investing activities 6.1 (2.0)
Net cash used by investing activities (504.0) (150.2)
Financing activities
Debt offering proceeds 1,300.0 —
Purchase of common shares for treasury (36.4) (4.2)
Cash dividends paid (86.8) (77.7)
Repayment of long-term debt (956.8) (18.5)
Payments on withholding tax on share awards (4.3) (10.7)
Debt financing costs (49.3) —
Other financing activities — (3.5)
Net cash provided (used) by financing activities 166.4 (114.6)
Effect of exchange rate changes on cash (20.9) (17.3)
Increase (decrease) in cash and cash equivalents 39.9 (48.3)
Cash and cash equivalents at beginning of year 601.2 649.5
Cash and cash equivalents at end of year $ 641.1 $ 601.2
13
Attachment 6
Avient Corporation
Business Segment Operations (Unaudited)
(In millions)
Operating income at the segment level does not include: special items as defined in Attachment 3; corporate general and
administration costs that are not allocated to segments; intersegment sales and profit eliminations; share-based compensation
costs; and certain other items that are not included in the measure of segment profit and loss that is reported to and reviewed by
the chief operating decision maker.
https://www.avient.com/sites/default/files/2024-02/AVNT Q4 2023 Earnings Press Release.pdf
https://www.avient.com/news-events
https://www.avient.com/
4
Forward-looking Statements
In this press release, statements that are not reported financial results or other historical
information are “forward-looking statements” within the meaning of the Private Securities
Litigation Reform Act of 1995.
2) Tax adjustments include the net tax impact from non-recurring income tax items, adjustments to uncertain tax position reserves and the
establishment, reversal or changes to valuation allowances.
10
Attachment 4
Avient Corporation
Condensed Consolidated Balance Sheets (Unaudited)
(In millions)
Year Ended
December 31,
2023 2022
ASSETS
Current assets:
Cash and cash equivalents $ 545.8 $ 641.1
Accounts receivable, net 399.9 440.6
Inventories, net 347.0 372.7
Other current assets 114.9 115.3
Total current assets 1,407.6 1,569.7
Property, net 1,028.9 1,049.2
Goodwill 1,719.3 1,671.9
Intangible assets, net 1,590.8 1,597.6
Operating lease assets, net 65.3 60.4
Other non-current assets 156.6 136.2
Total assets $ 5,968.5 $ 6,085.0
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Short-term and current portion of long-term debt $ 9.5 $ 2.2
Accounts payable 432.3 454.4
Current operating lease obligations 16.6 17.0
Accrued expenses and other current liabilities 315.2 395.8
Total current liabilities 773.6 869.4
Non-current liabilities:
Long-term debt 2,070.5 2,176.7
Pension and other post-retirement benefits 67.2 67.2
Deferred income taxes 281.6 342.5
Non-current operating lease obligations 43.2 40.9
Other non-current liabilities 394.4 235.5
Total non-current liabilities 2,856.9 2,862.8
SHAREHOLDERS' EQUITY
Avient shareholders’ equity 2,319.2 2,334.5
Noncontrolling interest 18.8 18.3
Total equity 2,338.0 2,352.8
Total liabilities and equity $ 5,968.5 $ 6,085.0
11
Attachment 5
Avient Corporation
Condensed Consolidated Statements of Cash Flows (Unaudited)
(In millions)
Year Ended
December 31,
2023 2022
Operating activities
Net income $ 76.2 $ 703.4
Adjustments to reconcile net income to net cash provided by operating activities:
Gain on sale of business, net of tax expense — (550.1)
Depreciation and amortization 186.9 157.6
Accelerated depreciation 1.9 5.5
Amortization of inventory step-up — 34.4
Deferred income tax (benefit) expense (61.3) 0.5
Share-based compensation expense 13.2 13.2
Changes in assets and liabilities, net of the effect of acquisitions:
Decrease in accounts receivable 38.6 32.6
Decrease in inventories 24.3 14.0
(Decrease) increase in accounts payable (22.2) 10.7
(Decrease) increase in pension and other post-retirement benefits (15.1) 7.1
Taxes paid on gain on sale of business (104.1) (2.8)
Accrued expenses and other assets and liabilities, net 63.2 (27.7)
Net cash provided by operating activities 201.6 398.4
Investing activities
Capital expenditures (119.4) (105.5)
Business acquisitions, net of cash acquired — (1,426.1)
Settlement of foreign exchange derivatives — 93.3
Net proceeds from divestiture 7.3 928.2
Proceeds from plant closures 7.6 6.1
Other investing activities 10.3 —
Net cash used by investing activities (94.2) (504.0)
Financing activities
Debt offering proceeds — 1,300.0
Purchase of common shares for treasury — (36.4)
Cash dividends paid (90.2) (86.8)
Repayment of long-term debt (105.8) (956.8)
Payments on withholding tax on share awards (3.4) (4.3)
Debt financing costs (2.3) (49.3)
Net cash (used) provided by financing activities (201.7) 166.4
Effect of exchange rate changes on cash (1.0) (20.9)
(Decrease) increase in cash and cash equivalents (95.3) 39.9
Cash and cash equivalents at beginning of year 641.1 601.2
Cash and cash equivalents at end of year $ 545.8 $ 641.1
12
Attachment 6
Avient Corporation
Business Segment Operations (Unaudited)
(In millions)
Operating income at the segment level does not include: special items as defined in Attachment 3; corporate general and
administration costs that are not allocated to segments; intersegment sales and profit eliminations; share-based compensation
costs; and certain other items that are not included in the measure of segment profit and loss that is reported to and reviewed
by the chief operating decision maker.
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520%25E2%2580%2593%2520Recast%2520Financial%2520Information%2520for%2520Discontinued%2520Operations.pdf
Slide 4 - Adjusted Financial Information Recast for DSS Divestiture
Reflects quarterly adjusted condensed financial data recast for DSS as a discontinued operation.
Table of Contents
POLYONE CORPORATION 3
GAAP Financial Information Recast for DSS Divestiture
Q1 2013 Q2 2013 Q3 2013 Q4 2013 2013 YTD Q1 2014 Q2 2014 Q3 2014 Q4 2014 2014 YTD Q1 2015 Q2 2015 Q3 2015 Q4 2015 2015 YTD
Sales 759.6$ 838.7$ 821.1$ 754.4$ 3,173.8$ 828.7$ 841.5$ 806.1$ 741.7$ 3,218.0$ 754.0$ 775.5$ 729.2$ 665.4$ 2,924.1$
Cost of sales 598.6 657.1 661.4 657.0 2,574.1 660.2 674.2 644.1 602.7 2,581.2 589.9 599.6 564.2 518.9 2,272.6
Gross margin 161.0 181.6 159.7 97.4 599.7 168.5 167.3 162.0 139.0 636.8 164.1 175.9 165.0 146.5 651.5
Selling and administrative 104.8 108.5 104.2 66.1 383.6 112.5 118.0 104.1 151.6 486.2 93.8 97.2 90.7 112.2 393.9
Income from equity affiliates and minority interest 0.1 - - 26.8 26.9 - - - - - - - - - -
Operating income (loss) 56.3 73.1 55.5 58.1 243.0 56.0 49.3 57.9 (12.6) 150.6 70.3 78.7 74.3 34.3 257.6
Interest expense, net (15.6) (16.6) (15.9) (15.2) (63.3) (15.5) (15.7) (15.4) (15.5) (62.1) (16.1) (16.2) (16.2) (15.5) (64.0)
Premium on early extinguishment of debt (10.6) - (5.2) - (15.8) - - - - - - - - (16.4) (16.4)
Other income (expense), net 1.5 (1.3) (1.5) - (1.3) (0.7) (0.4) (1.6) (1.4) (4.1) (0.6) (1.2) (1.7) 0.3 (3.2)
Income (loss) before income taxes 31.6 55.2 32.9 42.9 162.6 39.8 33.2 40.9 (29.5) 84.4 53.6 61.3 56.4 2.7 174.0
Income tax (expense) benefit (10.8) (21.6) (13.4) (16.6) (62.4) (10.7) (2.6) (12.0) 15.6 (9.7) (23.3) 4.3 (8.8) 2.3 (25.5)
Net income (loss) from continuing operations 20.8 33.6 19.5 26.3 100.2 29.1 30.6 28.9 (13.9) 74.7 30.3 65.6 47.6 5.0 148.5
Net (loss) income from discontinued operations, net of income taxes (5.7) 147.0 3.3 (2.1) 142.5 0.1 0.9 3.8 (1.1) 3.7 (0.1) 1.4 (3.1) (2.0) (3.8)
Net income (loss) 15.1 180.6 22.8 24.2 242.7 29.2 31.5 32.7 (15.0) 78.4 30.2 67.0 44.5 3.0 144.7
Less: Non-controlling interest 0.2 0.3 0.2 0.4 1.1 0.2 0.2 - 0.4 0.8 - (0.2) - 0.1 (0.1)
Net income (loss) attributable to PolyOne common shareholders 15.3$ 180.9$ 23.0$ 24.6$ 243.8$ 29.4$ 31.7$ 32.7$ (14.6)$ 79.2$ 30.2$ 66.8$ 44.5$ 3.1$ 144.6$
Earnings per share attributable to PolyOne common shareholders - Basic
Continuing operations 0.23$ 0.35$ 0.21$ 0.28$ 1.06$ 0.31$ 0.33$ 0.32$ (0.15)$ 0.82$ 0.34$ 0.73$ 0.55$ 0.06$ 1.69$
Discontinued operations (0.06)$ 1.50$ 0.03$ (0.02)$ 1.49$ -$ 0.01$ 0.04$ (0.01)$ 0.04$ -$ 0.02$ (0.04)$ (0.02)$ (0.04)$
Total 0.17$ 1.85$ 0.24$ 0.26$ 2.55$ 0.31$ 0.34$ 0.36$ (0.16)$ 0.86$ 0.34$ 0.75$ 0.51$ 0.04$ 1.65$
Earnings per share attributable to PolyOne common shareholders - Diluted
Continuing operations 0.22$ 0.34$ 0.20$ 0.27$ 1.05$ 0.31$ 0.33$ 0.31$ (0.15)$ 0.81$ 0.34$ 0.73$ 0.54$ 0.06$ 1.67$
Discontinued operations (0.06)$ 1.49$ 0.04$ (0.02)$ 1.48$ -$ 0.01$ 0.04$ (0.01)$ 0.04$ -$ 0.01$ (0.04)$ (0.02)$ (0.04)$
Total 0.16$ 1.83$ 0.24$ 0.25$ 2.53$ 0.31$ 0.34$ 0.35$ (0.16)$ 0.85$ 0.34$ 0.74$ 0.50$ 0.04$ 1.63$
Q1 2016 Q2 2016 Q3 2016 Q4 2016 2016 YTD Q1 2017
Sales 738.5$ 758.2$ 746.6$ 694.8$ 2,938.1$ 796.7$
Cost of sales 561.9 576.3 580.5 542.3 2,261.0 614.4
Gross margin 176.6 181.9 166.1 152.5 677.1 182.3
Selling and administrative 106.2 100.1 94.1 90.4 390.8 98.3
Operating income 70.4 81.8 72.0 62.1 286.3 84.0
Interest expense, net (14.6) (14.6) (15.1) (15.4) (59.7) (14.6)
Premium on early extinguishment of debt - (0.4) - - (0.4) (0.3)
Other income (expense), net - 0.1 (0.1) 0.4 0.4 (1.1)
Income before income taxes 55.8 66.9 56.8 47.1 226.6 68.0
Income tax expense (17.6) (16.8) (14.0) (12.0) (60.4) (19.7)
Net income from continuing operations 38.2 50.1 42.8 35.1 166.2 48.3
Net income (loss) from discontinued operations, net of income taxes 0.8 (0.1) (0.5) (1.4) (1.2) (1.4)
Net income 39.0 50.0 42.3 33.7 165.0 46.9
Less: Non-controlling interest 0.1 - - 0.1 0.2 -
Net income attributable to PolyOne common shareholders 39.1$ 50.0$ 42.3$ 33.8$ 165.2$ 46.9$
Earnings per share attributable to PolyOne common shareholders - Basic
Continuing operations 0.45$ 0.59$ 0.51$ 0.43$ 1.98$ 0.58$
Discontinued operations 0.01$ -$ (0.01)$ (0.02)$ (0.01)$ (0.01)$
Total 0.46$ 0.59$ 0.50$ 0.41$ 1.97$ 0.57$
Earnings per share attributable to PolyOne common shareholders - Diluted
Continuing operations 0.45$ 0.59$ 0.51$ 0.42$ 1.96$ 0.58$
Discontinued operations 0.01$ -$ (0.01)$ (0.02)$ (0.01)$ (0.01)$
Total 0.46$ 0.59$ 0.50$ 0.40$ 1.95$ 0.57$
POLYONE CORPORATION 4
Adjusted Financial Information Recast for DSS Divestiture
Q1 2013 Q2 2013 Q3 2013 Q4 2013 2013 YTD Q1 2014 Q2 2014 Q3 2014 Q4 2014 2014 YTD Q1 2015 Q2 2015 Q3 2015 Q4 2015 2015 YTD
Sales 759.6$ 838.7$ 821.1$ 754.4$ 3,173.8$ 828.7$ 841.5$ 806.1$ 741.7$ 3,218.0$ 754.0$ 775.5$ 729.2$ 665.4$ 2,924.1$
Cost of sales 601.6 670.6 656.6 606.9 2,535.7 656.0 660.1 637.0 592.6 2,545.7 588.7 597.4 561.0 511.0 2,258.1
Gross margin 158.0 168.1 164.5 147.5 638.1 172.7 181.4 169.1 149.1 672.3 165.3 178.1 168.2 154.4 666.0
Selling and administrative 102.4 106.2 107.6 107.5 423.7 109.6 108.4 100.0 94.5 412.5 91.6 93.1 88.1 96.5 369.3
Operating income 55.6 61.9 56.9 40.0 214.4 63.1 73.0 69.1 54.6 259.8 73.7 85.0 80.1 57.9 296.7
Interest expense, net (13.7) (16.6) (15.9) (15.2) (61.4) (15.5) (15.7) (15.4) (15.5) (62.1) (16.1) (16.2) (16.2) (15.5) (64.0)
Other income (expense), net 0.1 (1.3) (1.5) - (2.7) (0.7) (0.9) (1.7) (1.5) (4.8) (0.6) (1.2) (1.8) 0.3 (3.3)
Income before income taxes 42.0 44.0 39.5 24.8 150.3 46.9 56.4 52.0 37.6 192.9 57.0 67.6 62.1 42.7 229.4
Income tax expense (14.2) (16.1) (13.5) (9.8) (53.6) (14.9) (18.3) (16.6) (12.0) (61.8) (18.8) (21.3) (19.4) (12.1) (71.6)
Adjusted net income from continuing operations 27.8 27.9 26.0 15.0 96.7 32.0 38.1 35.4 25.6 131.1 38.2 46.3 42.7 30.6 157.8
Less: Non-controlling interest 0.2 0.3 0.2 0.4 1.1 0.2 0.2 - 0.4 0.8 - (0.2) - 0.1 (0.1)
Adjusted net income attributable to PolyOne common shareholders - continuing operations 28.0$ 28.2$ 26.2$ 15.4$ 97.8$ 32.2$ 38.3$ 35.4$ 26.0$ 131.9$ 38.2$ 46.1$ 42.7$ 30.7$ 157.7$
Adjusted earnings per share attributable to PolyOne common shareholders - Diluted 0.30$ 0.28$ 0.27$ 0.15$ 1.01$ 0.34$ 0.41$ 0.38$ 0.28$ 1.41$ 0.43$ 0.51$ 0.48$ 0.36$ 1.78$
Q1 2016 Q2 2016 Q3 2016 Q4 2016 2016 YTD Q1 2017
Sales 738.5$ 758.2$ 746.6$ 694.8$ 2,938.1$ 796.7$
Cost of sales 557.8 576.5 576.1 540.7 2,251.1 612.0
Gross margin 180.7 181.7 170.5 154.1 687.0 184.7
Selling and administrative 100.0 93.9 88.3 94.9 377.1 99.0
Operating income 80.7 87.8 82.2 59.2 309.9 85.7
Interest expense, net (14.6) (14.6) (15.1) (15.4) (59.7) (14.6)
Other (expense) income, net (0.2) 0.2 (0.1) 0.3 0.2 (1.2)
Income before income taxes 65.9 73.4 67.0 44.1 250.4 69.9
Income tax expense (21.0) (23.1) (20.7) (11.5) (76.3) (20.7)
Adjusted net income from continuing operations 44.9 50.3 46.3 32.6 174.1 49.2
Less: Non-controlling interest 0.1 - - 0.1 0.2 -
Adjusted net income attributable to PolyOne common shareholders - continuing operations 45.0$ 50.3$ 46.3$ 32.7$ 174.3$ 49.2$
Adjusted earnings per share attributable to PolyOne common shareholders - Diluted 0.53$ 0.59$ 0.55$ 0.39$ 2.06$ 0.59$
POLYONE CORPORATION 5
Business Segment and Data Recast for DSS Divestiture
Q1 2013 Q2 2013 Q3 2013 Q4 2013 2013 YTD Q1 2014 Q2 2014 Q3 2014 Q4 2014 2014 YTD Q1 2015 Q2 2015 Q3 2015 Q4 2015 2015 YTD
Sales:
Color, Additives and Inks 205.3 229.4 219.0 198.6 852.3 219.6 228.7 212.0 190.5 850.8 208.5 217.4 199.9 184.9 810.7
Specialty Engineered Materials 152.9 158.8 157.6 146.2 615.5 157.4 157.8 145.8 137.3 598.3 141.9 139.7 136.0 125.2 542.8
Performance Products and Solutions 166.6 210.3 207.4 188.9 773.2 207.6 211.2 213.0 184.8 816.6 175.9 190.3 175.2 152.7 694.1
PolyOne Distribution 268.0 275.1 275.0 257.1 1,075.2 284.1 287.0 280.5 262.8 1,114.4 265.7 266.8 259.5 242.1 1,034.1
Corporate and Eliminations (33.2) (34.9) (37.9) (36.4) (142.4) (40.0) (43.2) (45.2) (33.7) (162.1) (38.0) (38.7) (41.4) (39.5) (157.6)
Sales 759.6 838.7 821.1 754.4 3,173.8 828.7 841.5 806.1 741.7 3,218.0 754.0 775.5 729.2 665.4 2,924.1
Gross Margin:
Color, Additives and Inks 67.7 75.2 71.8 63.1 277.8 74.9 81.7 71.8 65.1 293.5 73.4 80.0 73.4 67.0 293.8
Specialty Engineered Materials 39.2 39.0 39.2 35.8 153.2 42.6 43.5 39.7 37.4 163.2 43.0 41.1 39.6 37.3 161.0
Performance Products and Solutions 24.0 26.9 27.6 23.5 102.0 28.0 29.0 29.2 22.8 109.0 22.5 27.4 27.2 24.8 101.9
PolyOne Distribution 28.2 28.1 27.6 24.7 108.6 29.8 28.8 29.3 26.1 114.0 27.8 30.2 29.4 27.2 114.6
Corporate and Eliminations 1.9 12.4 (6.5) (49.7) (41.9) (6.8) (15.7) (8.0) (12.4) (42.9) (2.6) (2.8) (4.6) (9.8) (19.8)
Gross Margin 161.0 181.6 159.7 97.4 599.7 168.5 167.3 162.0 139.0 636.8 164.1 175.9 165.0 146.5 651.5
Selling and Administrative Expense:
Color, Additives and Inks 43.5 44.3 42.9 43.1 173.8 44.5 44.0 41.7 38.4 168.6 39.6 40.4 38.9 39.5 158.4
Specialty Engineered Materials 23.4 24.0 24.6 24.0 96.0 24.3 24.6 21.3 20.6 90.8 19.9 21.0 19.6 20.9 81.4
Performance Products and Solutions 10.4 11.6 12.5 11.5 46.0 12.0 11.4 11.4 11.1 45.9 11.0 11.1 11.1 11.3 44.5
PolyOne Distribution 12.0 11.2 11.0 11.1 45.3 12.6 11.5 10.6 11.1 45.8 12.1 11.1 11.8 11.6 46.6
Corporate and Eliminations 15.5 17.4 13.2 (23.6) 22.5 19.1 26.5 19.1 70.4 135.1 11.2 13.6 9.3 28.9 63.0
Selling and Administrative Expense 104.8 108.5 104.2 66.1 383.6 112.5 118.0 104.1 151.6 486.2 93.8 97.2 90.7 112.2 393.9
Operating Income:
Color, Additives and Inks 24.2 30.9 28.9 20.0 104.0 30.4 37.7 30.1 26.7 124.9 33.8 39.6 34.5 27.5 135.4
Specialty Engineered Materials 15.8 15.0 14.6 11.8 57.2 18.3 18.9 18.4 16.8 72.4 23.1 20.1 20.0 16.4 79.6
Performance Products and Solutions 13.6 15.3 15.1 12.0 56.0 16.0 17.6 17.8 11.7 63.1 11.5 16.3 16.1 13.5 57.4
PolyOne Distribution 16.2 16.9 16.6 13.6 63.3 17.2 17.3 18.7 15.0 68.2 15.7 19.1 17.6 15.6 68.0
Corporate and Eliminations (13.5) (5.0) (19.7) 0.7 (37.5) (25.9) (42.2) (27.1) (82.8) (178.0) (13.8) (16.4) (13.9) (38.7) (82.8)
Operating Income (loss) 56.3 73.1 55.5 58.1 243.0 56.0 49.3 57.9 (12.6) 150.6 70.3 78.7 74.3 34.3 257.6
Q1 2016 Q2 2016 Q3 2016 Q4 2016 2016 YTD Q1 2017
Sales:
Color, Additives and Inks 204.9 212.2 195.9 184.7 797.7 211.8
Specialty Engineered Materials 141.0 143.3 146.2 135.3 565.8 159.1
Performance Products and Solutions 166.2 172.8 171.3 158.2 668.5 183.7
PolyOne Distribution 268.8 272.6 274.8 254.8 1,071.0 286.1
Corporate and Eliminations (42.4) (42.7) (41.6) (38.2) (164.9) (44.0)
Sales 738.5 758.2 746.6 694.8 2,938.1 796.7
Gross Margin:
Color, Additives and Inks 75.3 78.0 70.0 62.8 286.1 75.2
Specialty Engineered Materials 44.2 43.0 41.7 38.6 167.5 46.1
Performance Products and Solutions 32.4 33.0 29.2 26.6 121.2 33.9
PolyOne Distribution 30.7 29.5 29.6 27.3 117.1 31.4
Corporate and Eliminations (6.0) (1.6) (4.4) (2.8) (14.8) (4.3)
Gross Margin 176.6 181.9 166.1 152.5 677.1 182.3
Selling and Administrative Expense:
Color, Additives and Inks 40.4 39.8 38.6 39.8 158.6 40.1
Specialty Engineered Materials 20.8 21.6 21.2 22.8 86.4 22.5
Performance Products and Solutions 12.7 11.7 11.2 11.2 46.8 11.8
PolyOne Distribution 13.2 11.7 11.4 12.6 48.9 12.8
Corporate and Eliminations 19.1 15.3 11.7 4.0 50.1 11.1
Selling and Administrative Expense 106.2 100.1 94.1 90.4 390.8 98.3
Operating Income:
Color, Additives and Inks 34.9 38.2 31.4 23.0 127.5 35.1
Specialty Engineered Materials 23.4 21.4 20.5 15.8 81.1 23.6
Performance Products and Solutions 19.7 21.3 18.0 15.4 74.4 22.1
PolyOne Distribution 17.5 17.8 18.2 14.7 68.2 18.6
Corporate and Eliminations (25.1) (16.9) (16.1) (6.8) (64.9) (15.4)
Operating Income 70.4 81.8 72.0 62.1 286.3 84.0
POLYONE CORPORATION 6
Non-GAAP Reconciliations
Q1 2013 Q2 2013 Q3 2013 Q4 2013 2013 YTD Q1 2014 Q2 2014 Q3 2014 Q4 2014 2014 YTD Q1 2015 Q2 2015 Q3 2015 Q4 2015 2015 YTD
Sales 759.6 838.7 821.1 754.4 3,173.8 828.7 841.5 806.1 741.7 3,218.0 754.0 775.5 729.2 665.4 2,924.1
Gross margin - GAAP 161.0 181.6 159.7 97.4 599.7 168.5 167.3 162.0 139.0 636.8 164.1 175.9 165.0 146.5 651.5
Special items in gross margin (see slide 7) (3.0) (13.5) 4.8 50.1 38.4 4.2 14.1 7.1 10.1 35.5 1.2 2.2 3.2 7.9 14.5
Adjusted gross margin 158.0 168.1 164.5 147.5 638.1 172.7 181.4 169.1 149.1 672.3 165.3 178.1 168.2 154.4 666.0
Adjusted gross margin as a percent of sales 20.8% 20.0% 20.0% 19.6% 20.1% 20.8% 21.6% 21.0% 20.1% 20.9% 21.9% 23.0% 23.1% 23.2% 22.8%
Operating income - GAAP 56.3 73.1 55.5 58.1 243.0 56.0 49.3 57.9 (12.6) 150.6 70.3 78.7 74.3 34.3 257.6
Special items in operating income (see slide 7) (0.7) (11.2) 1.4 (18.1) (28.6) 7.1 23.7 11.2 67.2 109.2 3.4 6.3 5.8 23.6 39.1
Adjusted operating income 55.6 61.9 56.9 40.0 214.4 63.1 73.0 69.1 54.6 259.8 73.7 85.0 80.1 57.9 296.7
Adjusted operating income as a percent of sales 7.3% 7.4% 6.9% 5.3% 6.8% 7.6% 8.7% 8.6% 7.4% 8.1% 9.8% 11.0% 11.0% 8.7% 10.1%
Q1 2016 Q2 2016 Q3 2016 Q4 2016 2016 YTD Q1 2017
Sales 738.5 758.2 746.6 694.8 2,938.1 796.7
Gross margin - GAAP 176.6 181.9 166.1 152.5 677.1 182.3
Special items in gross margin (see slide 7) 4.1 (0.2) 4.4 1.6 9.9 2.4
Adjusted gross margin 180.7 181.7 170.5 154.1 687.0 184.7
Adjusted gross margin as a percent of sales 24.5% 24.0% 22.8% 22.2% 23.4% 23.2%
Operating income - GAAP 70.4 81.8 72.0 62.1 286.3 84.0
Special items in operating income (see slide 7) 10.3 6.0 10.2 (2.9) 23.6 1.7
Adjusted operating income 80.7 87.8 82.2 59.2 309.9 85.7
Adjusted operating income as a percent of sales 10.9% 11.6% 11.0% 8.5% 10.5% 10.8%
POLYONE CORPORATION 7
Summary of Special Items
Q1 2013 Q2 2013 Q3 2013 Q4 2013 2013 YTD Q1 2014 Q2 2014 Q3 2014 Q4 2014 2014 YTD Q1 2015 Q2 2015 Q3 2015 Q4 2015 2015 YTD
Cost of sales:
Restructuring Costs - - - (2.5) (2.5) (3.3) (13.2) (2.8) (7.4) (26.7) (0.2) (0.2) (1.0) (6.3) (7.7)
Environmental remediation costs (2.0) (1.3) (4.8) (52.6) (60.7) (0.9) (0.9) (5.9) (2.6) (10.3) (1.5) (2.0) (4.3) (1.5) (9.3)
Pension & other post-retirement benefits - mark-to-market adjustment - - - 1.6 1.6 - - - (2.0) (2.0) - - - (1.0) (1.0)
Reimbursement of previously incurred environmental costs 5.2 14.9 - 3.4 23.5 - - 1.6 2.1 3.7 0.5 - 2.1 0.9 3.5
Acquisition related adjustments (0.2) (0.1) - - (0.3) - - - (0.2) (0.2) - - - - -
Impact on cost of sales 3.0 13.5 (4.8) (50.1) (38.4) (4.2) (14.1) (7.1) (10.1) (35.5) (1.2) (2.2) (3.2) (7.9) (14.5)
Selling and administrative expense:
Restructuring, legal and other (2.3) (1.9) 4.1 (1.0) (1.1) (2.7) (9.3) (3.9) 1.0 (14.9) (1.9) (3.4) (1.8) (3.9) (11.0)
Unrealized gain on foreign currency option contracts 0.4 0.2 0.3 0.2 1.1 - - - - - - - - - -
Pension & other post-retirement benefits - mark-to-market adjustment - - 42.4 42.4 - - - (54.5) (54.5) - - - (10.6) (10.6)
Acquisition/divestiture related costs (0.5) (0.6) (1.0) (0.2) (2.3) (0.2) (0.3) (0.2) (3.6) (4.3) (0.3) (0.7) (0.8) (1.2) (3.0)
Impact on selling and administrative expense (2.4) (2.3) 3.4 41.4 40.1 (2.9) (9.6) (4.1) (57.1) (73.7) (2.2) (4.1) (2.6) (15.7) (24.6)
Gain on sale of investment in equity affiliates 0.1 - - 26.8 26.9 - - - - - - - - - -
Impact on operating income 0.7 11.2 (1.4) 18.1 28.6 (7.1) (23.7) (11.2) (67.2) (109.2) (3.4) (6.3) (5.8) (23.6) (39.1)
- - -
Debt extinguishment costs (10.6) - (5.2) - (15.8) - - - - - - - - (16.4) (16.4)
Bridge loan commitment fees - interest expense (1.9) - - - (1.9) - - - - - - - - - -
Other income (expense), net 1.4 - - - 1.4 - 0.5 0.1 0.1 0.7 - - 0.1 - 0.1
Impact on income before income taxes (10.4) 11.2 (6.6) 18.1 12.3 (7.1) (23.2) (11.1) (67.1) (108.5) (3.4) (6.3) (5.7) (40.0) (55.4)
Income tax benefit on above special items 3.9 (5.3) 1.9 (7.1) (6.6) 2.6 10.5 4.5 24.0 41.6 1.4 1.7 1.0 14.6 18.7
Tax adjustments (0.5) (0.2) (1.8) 0.3 (2.2) 1.6 5.2 0.1 3.6 10.5 (5.9) 23.9 9.6 (0.2) 27.4
Impact of special items on net income (7.0) 5.7 (6.5) 11.3 3.5 (2.9) (7.5) (6.5) (39.5) (56.4) (7.9) 19.3 4.9 (25.6) (9.3)
Diluted earnings per common share impact (0.08)$ 0.06$ (0.07)$ 0.12$ 0.04$ (0.03)$ (0.08)$ (0.07)$ (0.43)$ (0.60)$ (0.09)$ 0.22$ 0.06$ (0.30)$ (0.11)$
Q1 2016 Q2 2016 Q3 2016 Q4 2016 2016 YTD Q1 2017
Cost of sales:
Restructuring Costs 0.1 (1.0) - (0.2) (1.1) -
Environmental remediation costs (1.7) (2.1) (2.4) (2.2) (8.4) (2.2)
Pension & other post-retirement benefits - mark-to-market adjustment - - - 0.3 0.3 -
Reimbursement of previously incurred environmental costs - 5.3 - 0.8 6.1 -
Acquisition related adjustments (2.5) (2.0) (2.0) (0.3) (6.8) (0.2)
Impact on cost of sales (4.1) 0.2 (4.4) (1.6) (9.9) (2.4)
Selling and administrative expense:
Restructuring, legal and other (5.9) (5.6) (5.3) (3.0) (19.8) 1.4
Unrealized gain on foreign currency option contracts - - - - - -
Pension & other post-retirement benefits - mark-to-market adjustment - - - 8.1 8.1 -
Acquisition/divestiture related costs (0.3) (0.6) (0.5) (0.6) (2.0) (0.7)
Impact on selling and administrative expense (6.2) (6.2) (5.8) 4.5 (13.7) 0.7
Gain on sale of investment in equity affiliates - - - - - -
Impact on operating income (10.3) (6.0) (10.2) 2.9 (23.6) (1.7)
Debt extinguishment costs - (0.4) - - (0.4) (0.3)
Bridge loan commitment fees - interest expense - - - - - -
Other income (expense), net 0.2 (0.1) - 0.1 0.2 0.1
Impact on income before income taxes (10.1) (6.5) (10.2) 3.0 (23.8) (1.9)
Income tax benefit on above special items 3.8 2.6 3.7 (1.8) 8.3 0.9
Tax adjustments (0.4) 3.7 3.0 1.3 7.6 0.1
Impact of special items on net income (6.7) (0.2) (3.5) 2.5 (7.9) (0.9)
Diluted earnings per common share impact (0.08)$ -$ (0.04)$ 0.03$ (0.10)$ (0.01)$
Recast Financial Information for Discontinued Operations
Table of Contents
GAAP Financial Information Recast for DSS Divestiture
Adjusted Financial Information Recast for DSS Divestiture
Business Segment and Data Recast for DSS Divestiture
Non-GAAP Reconciliations
Summary of Special Items
https://www.avient.com/sites/default/files/2021-01/avient-colorants-belgium-registered-publication.pdf
Article 4.
B
ijl
ag
en
b
ij
he
t B
el
gi
sc
h
S
ta
at
sb
la
d
- 0
2/
12
/2
02
0
- A
nn
ex
es
d
u
M
on
ite
ur
b
el
ge
- suiteVolet B
Au verso : Nom et signature (pas applicable aux actes de type "Mention").
ayant pouvoir de représenter la personne morale à l'égard des tiers
Mentionner sur la dernière page du Volet B : Au recto : Nom et qualité du notaire instrumentant ou de la personne ou des personnes
Moniteur
belge
Réservé
au
Mod PDF 19.01
L'assemblée confère tous pouvoirs à Monsieur David Vanderstraeten, Monsieur Louis Casteleyn,
Monsieur Lorenz Taets et Madame Bénédicte Fanard, qui, à cet effet, élisent domicile Rue de la
Régence 4 à 1000 Bruxelles, et à tout autre avocat ou paralegal du cabinet d'avocats Jones Day,
chacun pouvant agir individuellement et ayant pouvoir de substitution, afin d'assurer les formalités
auprès d'un guichet d'entreprise en vue d'assurer l'inscription/la modification des données dans la
Banque Carrefour des Entreprises et, le cas échéant, auprès de l'Administration de la Taxe sur la
Valeur Ajoutée.
https://www.avient.com/sites/default/files/2024-10/Avient Announces Third Quarter 2024 Results.pdf
For more information, visit https://www.avient.com.
4
Forward-looking Statements
In this press release, statements that are not reported financial results or other historical
information are "forward-looking statements" within the meaning of the Private Securities
Litigation Reform Act of 1995.
2) Tax adjustments include the net tax impact from non-recurring income tax items and certain adjustments to uncertain tax position reserves
and valuation allowances.
9
Attachment 4
Avient Corporation
Condensed Consolidated Balance Sheets
(In millions)
(Unaudited)
September 30,
2024 December 31, 2023
ASSETS
Current assets:
Cash and cash equivalents $ 505.7 $ 545.8
Accounts receivable, net 465.1 399.9
Inventories, net 377.8 347.0
Other current assets 108.8 114.9
Total current assets 1,457.4 1,407.6
Property, net 973.5 1,028.9
Goodwill 1,716.8 1,719.3
Intangible assets, net 1,542.5 1,590.8
Deferred income taxes 133.1 92.3
Other non-current assets 224.0 129.6
Total assets $ 6,047.3 $ 5,968.5
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Short-term and current portion of long-term debt $ 7.8 $ 9.5
Accounts payable 425.9 432.3
Accrued expenses and other current liabilities 460.8 331.8
Total current liabilities 894.5 773.6
Non-current liabilities:
Long-term debt 2,059.9 2,070.5
Pension and other post-retirement benefits 63.7 67.2
Deferred income taxes 289.1 281.6
Other non-current liabilities 359.9 437.6
Total non-current liabilities 2,772.6 2,856.9
SHAREHOLDERS' EQUITY
Avient shareholders’ equity 2,363.0 2,319.2
Noncontrolling interest 17.2 18.8
Total equity 2,380.2 2,338.0
Total liabilities and equity $ 6,047.3 $ 5,968.5
10
Attachment 5
Avient Corporation
Condensed Consolidated Statements of Cash Flows (Unaudited)
(In millions)
Nine Months Ended
September 30,
2024 2023
Operating activities
Net income $ 122.2 $ 47.8
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 133.1 142.6
Accelerated depreciation 1.2 1.9
Share-based compensation expense 12.5 9.7
Changes in assets and liabilities:
Increase in accounts receivable (65.7) (5.7)
(Increase) decrease in inventories (30.2) 16.5
Decrease in accounts payable (5.7) (59.1)
Taxes paid on gain on sale of business — (104.1)
Accrued expenses and other assets and liabilities, net (33.2) (2.5)
Net cash provided by operating activities 134.2 47.1
Investing activities
Capital expenditures (80.8) (75.0)
Net proceeds from divestiture — 7.3
Proceeds from plant closures 3.4 —
Other investing activities (2.1) 2.3
Net cash used by investing activities (79.5) (65.4)
Financing activities
Proceeds from long-term borrowings 650.0 —
Payments on long-term borrowings (659.1) (103.8)
Cash dividends paid (70.5) (67.6)
Debt financing costs (9.6) (2.3)
Other financing activities (4.6) (2.3)
Net cash used by financing activities (93.8) (176.0)
Effect of exchange rate changes on cash (1.0) (7.2)
Decrease in cash and cash equivalents (40.1) (201.5)
Cash and cash equivalents at beginning of year 545.8 641.1
Cash and cash equivalents at end of period $ 505.7 $ 439.6
11
Attachment 6
Avient Corporation
Business Segment Operations (Unaudited)
(In millions)
Operating income and earnings before interest, taxes, depreciation and amortization (EBITDA) at the segment level does not
include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to
segments; intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not
included in the measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker.
https://www.avient.com/sites/default/files/2023-12/Polystrand Thermoplastic Composite Panel Application _ Install Guide.pdf
Example: Deflection for 24 inch panel = Chart value *[12 / 24]
Performance Comparison
Hammerhead Panels and Marine Plywood
INSTALLATION INSTRUCTIONS
∠Θ°
CUTTING & DRILLING
Recommended blade: Industrial fine cut-off saw blade, 10" x 80 teeth 38° ATB grind with 5/8" bore,
PTFE coating
Recommended router bits: 3/8" diameter, 4 flute TiAlN (titanium aluminum nitride) coated carbide bit
PANEL SHAPING
• Determine bend angle
• Cut relief
• Heat core to softening point
• Bend, hold, and cool
• Glue joint for added strength
FINISHING
Gel coat finish is possible with minimal surface preparation.
https://www.avient.com/sites/default/files/2021-09/mevopur-colors-and-additives-for-ivd-devices-application-bulletin-cn.pdf
在不限制本声明的一般性的情况下,不得将埃万特的产品用于旨在用于以下目的的任何医疗器械应用:
(1) 接触人体组织或体液长达30天或更长时间;
(2)“整形”(整容或重建)手术;
(3) 生殖植入物或任何节育器械;或者
(4) 用于支持或维持人类生命的永久性(超过30天)植入式医疗器械中的任何关键组件。
https://www.avient.com/investor-center/news/polyone-announces-first-quarter-2019-results
Attachment 4
https://www.avient.com/knowledge-base/article/thermoplastic-elastomer-tpe-faqs
4.